Parkinson’s disease - search results

Research shows that a new form of non-invasive brain surgery using a focused form of ultrasound will prove invaluable for with Parkinson’s symptoms.

The death rate from Parkinson’s disease has risen by 63% in the United States, according to a new study.

Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.

Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.

Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.

Associate Professor Petr Broz discusses pyroptotic cell death, the controlled cellular explosion that can harm your health.

María J. Peláez1, Prashant Dogra1, Zhihui Wang1, Vittorio Cristini1 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.

Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.

Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.

Pamela Lein and Rhianna Morgan discuss organosulfates and the growing connection between air pollution and neurologic disease The World Health Organization (WHO) estimates that traffic-related air pollution (TRAP) caused by gasoline and diesel emissions from automobiles, trucks, locomotives, ships and airplanes is responsible for more than 1 million premature deaths...

Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.

Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for degenerative diseases.

The work of the EU Joint Programme – Neurodegenerative Disease Research (JPND) which aims to tackle the challenge of these diseases, in particular, Alzheimer’s, is discussed here

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...

The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s My PD Journey is a multi-stakeholder European coalition led by the European Parkinson’s Disease Association (EPDA) and it is a positive development in terms of the positive progress being made for...

Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure

Chief Executive of the Huntington’s disease Association, Cath Stanley explores the symptoms, causes, and the vital role of research within the field

Prof Michael R Hamblin of the Wellman Center for Photomedicine at Massachusetts General Hospital discusses a new light-based therapy for Alzheimer’s disease

Professor Duncan McHale, Head Global Exploratory Development at UCB discusses the challenge of developing drugs to treat neurodegenerative diseases